{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:25Z","timestamp":1792677625199,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2534,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01HL103172-03"],"award-info":[{"award-number":["K01HL103172-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL114561"],"award-info":[{"award-number":["R01HL114561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL117658"],"award-info":[{"award-number":["U01HL117658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.exphem.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T17:25:41Z","timestamp":1430155541000},"page":"546-553.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases \u03b3-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model"],"prefix":"10.1016","volume":"43","author":[{"given":"Angela","family":"Rivers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestis","family":"Vaitkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Armila","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzon","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Jagadeeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kouznetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DeSimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.04.005_bib1","series-title":"The Molecular Basis of Blood Diseases","article-title":"Chapter 7. Human hemoglobins: Sickle hemoglobin and other mutants","author":"Bunn","year":"2001"},{"key":"10.1016\/j.exphem.2015.04.005_bib2","series-title":"The Molecular Basis of Blood Diseases","article-title":"Chapter 6. The thalassemias","author":"Wheatherall","year":"2001"},{"key":"10.1016\/j.exphem.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","article-title":"Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?","volume":"63","author":"Powars","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hoc.2013.11.009","article-title":"Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies","volume":"28","author":"Perrine","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/180326a0","article-title":"Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin","volume":"180","author":"Ingram","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/abio.2001.5358","article-title":"Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS (alpha2gammabetaS) in sickle cell disease","volume":"298","author":"Ofori-Acquah","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.exphem.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/275238a0","article-title":"Requirement for therapeutic inhibition of sickle haemoglobin gelation","volume":"275","author":"Sunshine","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/asheducation-2003.1.14","article-title":"Hemoglobinopathies","volume":"2003","author":"Atweh","year":"2003","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2015.04.005_bib10","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/MCB.00714-14","article-title":"Fetal globin gene repressors as drug targets for molecular therapies to treat the beta-globinopathies","volume":"34","author":"Suzuki","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.04.005_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","article-title":"National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease","volume":"148","author":"Brawley","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.exphem.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bbagrm.2013.05.002","article-title":"The histone LSD1 demethylase in stemness and cancer transcription programs","volume":"1829","author":"Amente","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.7554\/eLife.00633","article-title":"Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation","volume":"2","author":"Kerenyi","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.exphem.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/leu.2012.157","article-title":"Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation","volume":"26","author":"Sprussel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.3101","article-title":"Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction","volume":"19","author":"Shi","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1073\/pnas.1303976110","article-title":"Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1128\/MCB.25.9.3443-3451.2005","article-title":"Adult stage gamma-globin silencing is mediated by a promoter direct repeat element","volume":"25","author":"Omori","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/MCB.05310-11","article-title":"Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic beta-type globin promoters in differentiated adult erythroid cells","volume":"31","author":"Cui","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1101\/gad.1897310","article-title":"Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6","volume":"24","author":"Xu","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/cn200104y","article-title":"Brain-penetrant LSD1 inhibitors can block memory consolidation","volume":"3","author":"Neelamegam","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.exphem.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","article-title":"Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"e36846","DOI":"10.1371\/journal.pone.0036846","article-title":"Effect of AGM and fetal liver-derived stromal cell lines on globin expression in adult baboon (P.\u00a0anubis) bone marrow-derived erythroid progenitors","volume":"7","author":"Lavelle","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2015.04.005_bib25","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1182\/blood-2012-09-456079","article-title":"Quantitative analysis of murine terminal erythroid differentiation in\u00a0vivo: novel method to study normal and disordered erythropoiesis","volume":"121","author":"Liu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/MCB.01799-07","article-title":"DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B","volume":"28","author":"Palii","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mrfmmm.2010.09.004","article-title":"The role of the DNA hypermethylating agent budesonide in the decatenating activity of DNA topoisomerase II","volume":"694","author":"Orta","year":"2010","journal-title":"Mutat Res"},{"key":"10.1016\/j.exphem.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd4154","article-title":"Histone lysine demethylases as targets for anticancer therapy","volume":"12","author":"Hojfeldt","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng.268","article-title":"The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation","volume":"41","author":"Wang","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1096\/fj.13-242669","article-title":"Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal beta-like globin genes","volume":"28","author":"Roosjen","year":"2014","journal-title":"FASEB J"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:04:03Z","timestamp":1654923843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0301472X15001320"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.04.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases \u03b3-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}